Hi phlipper
I don't know if this aspect has been discussed previously, but the extension study (aka "new trial" thread of a few days back) indicates that this new trial will extend out to January 2023 .... dosing for 32 months ... so the question is
will the American TGA delay any approval until after the results are in for this new trial?
If "yes" then we have just been delayed by another year (yes/no?)
If you are talking to Jon perhaps he could clarify and you could let us know
thanks in advance
D
Hi phlipperI don't know if this aspect has been discussed...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.39 |
Change
-0.470(2.37%) |
Mkt cap ! $2.478B | |||
| Open | High | Low | Value | Volume |
| $19.70 | $19.77 | $19.28 | $10.38M | 534.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2680 | $19.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.41 | 362 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |